These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 868900)

  • 21. The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures.
    Pfister P; Hobbie S; Vicens Q; Böttger EC; Westhof E
    Chembiochem; 2003 Oct; 4(10):1078-88. PubMed ID: 14523926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ANT(4')I: a new aminoglycoside nucleotidyltransferase found in "staphylococcus aureus" (author's transl)].
    Le Goffic F; Baca B; Soussy CJ; Dublanchet A; Duval J
    Ann Microbiol (Paris); 1976 Apr; 127(3):391-9. PubMed ID: 1047990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-N-aminoglycoside acetyltransferase.
    Culebras E; Martínez JL; Baquero F; Pérez-Díaz JC
    J Antimicrob Chemother; 1996 May; 37(5):881-9. PubMed ID: 8737138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections].
    Kowalska-Krochmal B; Dolna I; Dobosz A; Wrzyszcz E; Gościniak G
    Med Dosw Mikrobiol; 2008; 60(3):205-14. PubMed ID: 19143174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
    Recht MI; Douthwaite S; Puglisi JD
    EMBO J; 1999 Jun; 18(11):3133-8. PubMed ID: 10357824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE; McGee ZA; Farrar WE
    J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive study to investigate the role of various aminoglycoside resistance mechanisms in clinical isolates of Acinetobacter baumannii.
    Sheikhalizadeh V; Hasani A; Ahangarzadeh Rezaee M; Rahmati-Yamchi M; Hasani A; Ghotaslou R; Goli HR
    J Infect Chemother; 2017 Feb; 23(2):74-79. PubMed ID: 27889248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deoxygenation of aminoglycosides.
    Tsuchiya T
    Jpn J Antibiot; 1979 Dec; 32 Suppl():S129-35. PubMed ID: 398898
    [No Abstract]   [Full Text] [Related]  

  • 32. [Aminoglycoside modifying enzymes (author's transl)].
    Wiedemann B; Weppelmann G
    Immun Infekt; 1981; 9(3):106-12. PubMed ID: 7251044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK.
    Hidalgo L; Hopkins KL; Gutierrez B; Ovejero CM; Shukla S; Douthwaite S; Prasad KN; Woodford N; Gonzalez-Zorn B
    J Antimicrob Chemother; 2013 Jul; 68(7):1543-50. PubMed ID: 23580560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss and gain of aminoglycoside resistance in global clone 2 Acinetobacter baumannii in Australia via modification of genomic resistance islands and acquisition of plasmids.
    Nigro SJ; Hall RM
    J Antimicrob Chemother; 2016 Sep; 71(9):2432-40. PubMed ID: 27246238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups.
    J Chemother; 1995 Jun; 7 Suppl 2():17-30. PubMed ID: 8622108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanisms of inactivation of aminosides. Relationship to phenotype in Gram negative bacilli].
    Witchitz JL
    Nouv Presse Med; 1975 Sep; 4(30):2187-90. PubMed ID: 52143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
    Al-Asadi MJ; Towner K; Greenwood D
    J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
    Price KE; DeFuria MD; Pursiano TA
    J Infect Dis; 1976 Nov; 134 SUPPL():S249-61. PubMed ID: 62814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.
    Shakil S; Khan R; Zarrilli R; Khan AU
    J Biomed Sci; 2008 Jan; 15(1):5-14. PubMed ID: 17657587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.